Literature DB >> 2394744

Protein kinase C heterogeneity in GH4C1 rat pituitary cells. Characterization of a Ca2(+)-independent phorbol ester receptor.

S Kiley1, D Schaap, P Parker, L L Hsieh, S Jaken.   

Abstract

Clonal GH4C1 rat pituitary cells are heterogeneous with respect to phorbol dibutyrate receptors (PDBu-R) and protein kinase C (PKC) content. GH cell PDBu-Rs can be separated into two categories based on Ca2(+)-modulation of receptor affinity. Approximately 70% of the cytosolic PDBu-Rs demonstrate Ca2(+)-sensitive receptor affinity and redistribute from the soluble to the particulate fraction in the presence of excess Ca2+. The other 30% of the receptors remain in the cytosol in the presence of excess Ca2+. Their receptor affinity is Ca2(+)-independent. Northern blot hybridization and immunoblot analysis showed that GH4C1 cells express Ca2(+)-independent epsilon-PKC as well as Ca2(+)-dependent alpha- and beta-PKCs. Cell lysis in Ca2+ caused the redistribution of greater than 95% of alpha- and beta-PKC to the particulate fraction, whereas approximately 90% of the epsilon-PKC remained in the cytosol. In contrast, brief treatment of GH cell cultures with PDBu or thyrotropin-releasing hormone caused redistribution of all three isozymes. Prolonged treatment with PDBu down-modulated all three isozymes but at different rates and to different extents. In contrast, prolonged thyrotropin-releasing hormone treatment selectively down-modulated epsilon-PKC. These results demonstrate that GH cells have both Ca2(+)-sensitive and -insensitive PKCs and PDBu-Rs and that both populations are regulated by agonists that control prolactin synthesis and secretion by these cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Role of protein kinase C in the inhibitory action of trophoblast interferons on expression of the oxytocin receptor in sheep endometrium.

Authors:  D R Abayasekara; E L Sheldrick; H C Flick-Smith; A P Flint
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

2.  Protein kinase C isoforms in pituitary cells displaying differential sensitivity to phorbol ester.

Authors:  D J MacEwan; M S Johnson; R Mitchell
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis.

Authors:  J M Lord; J Pongracz
Journal:  Clin Mol Pathol       Date:  1995-04

4.  Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity.

Authors:  E K Tang; M D Houslay
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

5.  Protein kinase C isozymes epsilon and alpha in murine erythroleukemia cells.

Authors:  C T Powell; L Leng; L Dong; H Kiyokawa; X Busquets; K O'Driscoll; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

6.  Extending the C2 domain family: C2s in PKCs delta, epsilon, eta, theta, phospholipases, GAPs, and perforin.

Authors:  C P Ponting; P J Parker
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

Review 7.  Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.

Authors:  E M Deacon; J Pongracz; G Griffiths; J M Lord
Journal:  Mol Pathol       Date:  1997-06

8.  Involvement of protein kinase C in growth regulation of human meningioma cells.

Authors:  T Todo; R Fahlbusch
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  The protein kinase C-related PKC-L(eta) gene product is localized in the cell nucleus.

Authors:  H Greif; J Ben-Chaim; T Shimon; E Bechor; H Eldar; E Livneh
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Stimulation of endogenous ADP-ribosylation by brefeldin A.

Authors:  M A De Matteis; M Di Girolamo; A Colanzi; M Pallas; G Di Tullio; L J McDonald; J Moss; G Santini; S Bannykh; D Corda
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.